New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma
Purpose: Glioblastoma is an aggressive brain tumor with high mortality and a median survival of about 15 months. Starting from our previous published compound, MV1035 that inhibited migration and invasiveness of glioblastoma U87 cells, and also exhibited a synergic effect in combination with the alk...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2024-07-01
|
| Edice: | Results in Chemistry |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2211715624003412 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|